MDMartina Hrčka Dubničková

Martina Hrčka Dubničková

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martina Hrčka Dubničková has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Dominika Nádaská

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, P.O.Box 90, SK-820 18 Bratislava, Slovakia

    2 shared publications
  • Ivan Malík

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia

    2 shared publications
  • Jozef Csöllei

    Department of Chemical Drugs, Faculty of Pharmacy, Masaryk University in Brno, Palackého Třída 1946/1, CZ-612 00 Brno, Czech Republic

    2 shared publications
  • Emil Švajdlenka

    Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-820 18 Bratislava 218, P.O. BOX 90 Bratislava, Slovakia

    1 shared publication
  • Fils Andriamainty

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia

    1 shared publication
  • Gabriela Greifová

    Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-820 18 Bratislava 218, P.O. BOX 90 Bratislava, Slovakia

    1 shared publication

Latest Publications

  • Open Access

    Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents

    by Dominika Nádaská, Tomáš Sádecký, Lucia Račková, Martina Hrčka Dubničková, Fils Andriamainty, Petr Mokrý, Simona Gover, Vladimír Garaj, Jozef Csöllei, Ivan Malík

    This research aimed to evaluate structural, physicochemical and pharmacokinetic characteristics of racemic 2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl 4-[(alkoxycarbonyl)amino]benzoates (Ib)–(IVb) and 2-hydroxy-3-[4-(R-substituted phenyl)piperazin-1-yl]propyl 4-[(alkoxycarbonyl)amino]benzoates (1b)–(12b), while further extending the in vitro screening of their racemic salts, 1-(3-{4-[(alkoxycarbonyl)amino]benzoyloxy}-2-hydroxypropyl)-4-(R-substituted phenyl)piperazin-1-ium chlorides (I)–(IV) and (1)–(12) (alkoxy = methoxy to butoxy in all of these series, and R = H, 4′-F, 2′-F or 2′-OCH3), against several mycobacterial species, including a slow-growing virulent Mycobacterium tuberculosis (Mtb) H37Rv strain. The values of structural, physicochemical and several pharmacokinetic descriptors of the compounds (Ib)–(IVb) and (1b)–(12b) were generated in silico, employing a palette of interactive web-based engines and standalone software packages. The obtained data allowed for exploration of their mutual relationships through a chemometric principal component analysis method. The predicted outputs were compared to the values of respective descriptors defining antimycobacterial drugs approved worldwide for therapeutic use in human medicine. Molecular docking (MD) analyses were carried out to explore the possibilities of whether particular (R)- and (S)-stereoisomers of non-protonated derivatives, as well as (R)- and (S)-stereoisomeric forms of their salts (I)–(IV) and (1)–(12) would effectively interact with a proposed pharmacological target, adenosine 5′-triphosphate (ATP) synthase. This membrane–protein complex was considered essential for energy metabolism and survival of various mycobacterial species. Respecting the fundamental structural arrangement of more efficient salts, the importance of their structural and spatial features was highlighted to achieve relative effective interactions with particular subunits of ATP synthase present in Mtb H37Rv. The results of the MD evaluations could contribute to the understanding of how these compounds inhibited growth of Mtb H37Rv. 1-(3-{4-[(Butoxycarbonyl)amino]benzoyloxy}-2-hydroxypropyl)-4-phenylpiperazin-1-ium chloride (IV) with a minimum inhibitory concentration (MIC) value of 62.5 μM estimated in vitro and 1-(3-{4-[(butoxycarbonyl)amino]benzoyloxy}-2-hydroxypropyl)-4-(2-methoxyphenyl)piperazin-1-ium chloride (12) with MIC = 16 μM, as the most effective anti-Mtb H37Rv agents of each series of the salts, were screened in vitro to investigate their antiproliferative or (eventual) cytotoxic properties using a normal human dermal fibroblast cell line. The derivative (IV) decreased cell viability slightly more compared to the molecule (12).

  • Open Access

    New N-Arylpiperazine-Based Compounds as Potential Inhibitors of Purinergic P2X7-Associated Signaling

    by Gabriela Greifová, Martina Hrčka Dubničková, Dominika Nádaská, Róbert Šandrik, Iva Kapustíková, Emil Švajdlenka, Martin Pisárčik, Jozef Csöllei, Ivan Malík

    This research paper focused on the synthesis of 1-[2-hydroxy-3-(phenylcarbamoyloxy)propyl]-4-(R1, R2-substituted phenyl)piperazin-1-ium chlorides (I)–(III), containing R1, R2 = H, Cl and/or OCH3, and the evaluation of some of their physicochemical parameters. The in vitro biological investigation of these N-arylpiperazine (NAP) derivatives consisted in assessing their impact on purinergic P2X7-associated signaling, that is, the evaluation of antioxidant, anti-inflammatory and immunomodulatory characteristics. The ultraviolet type C (UVC) irradiation (λ = 254 nm, 0.954 kJ/m2) induced a pronounced stress response in human leukocytes without marked cytotoxicity while maintaining high cell viability (≥90%), as evidenced by increased interleukin (IL)-1β production (94%), elevated IL-1β mRNA expression, enhanced lipid peroxidation (66%), and increased intracellular adenosine 5′-triphosphate (ATP; 97%), respectively. Under basal conditions, these lipophilic NAPs, defined with logarithmic values of retention (capacity) factors corresponding to 100% water in isocratic elution RP-HPLC, i.e., kw descriptors (varying from 2.3829 to 4.3689), and isocratic chromatographic hydrophobicity index (φ0) parameters (ranging from 0.7578 to 0.8842), reduced IL-1β production (by 26–63%) and enhanced superoxide dismutase (SOD) activity (up to 64%) without inducing oxidative damage. Under UVC-induced stress, all evaluated compounds decreased lipid peroxidation (up to 45%) and significantly increased antioxidant enzyme activities, including SOD (up to 223%) as well as catalase (up to 145%). The observed effects were associated with changes in intracellular ATP levels and redox-related parameters. In the experiments described in this paper, intracellular ATP was measured so that no direct conclusions could be drawn regarding the extracellular ATP-dependent activation of purinergic receptors, including P2X7. Overall, the results demonstrated that variations within the structure of these NAPs significantly affected compounds’ biological activity, highlighting their potential for further optimization as cytoprotective and anti-inflammatory agents.